Dataset Information


The human natural killer cytotoxic cell line NK-92, once armed with a murine CD16 receptor, represents a convenient cellular tool for the screening of mouse mAbs according to their ADCC potential.

ABSTRACT: To take advantage of the large number of well-characterized mouse immunoglobulins (IgGs) for the study of antibody-dependent cell-mediated cytotoxicity (ADCC) in human cells, we armed human cytotoxic lymphocytes with a mouse receptor for the Fc portion of IgG antibodies. The human ??-92 natural killer cell line was transduced with a mouse receptor gene (mCD16), which was stably expressed on the cell surface (referred to as NK-92 (mCD16) ). When tested against a B-lymphoblastoid cell line (BLCL) coated with mouse anti-CD20 IgG1, IgG2a or IgG2b monoclonal antibodies (mAbs), the newly expressed mouse Fc receptor enabled the NK-92 (mCD16) cells to kill the BLCL by ADCC. Next, using the NK-92 (mCD16) we compared mouse mAbs directed at B lineage specific CD antigens for their ability to induce ADCC against human Epstein-Barr virus- infected B lymphoblastoid (for anti-CD19, -CD20 and -CD21) or against myeloma (for anti-CD38 and -CD138) target cells. Our results demonstrated that the "NK-92 (mCD16) assay" allows convenient and sensitive discrimination of mouse mAbs for their ability to mediate ADCC in a human cellular system. In addition, our results provide examples of dissociation between opsonization and target cell killing through ADCC. These "murinized" human effector cells thus represent a convenient cellular tool for the study of ADCC.

SUBMITTER: Clemenceau B 

PROVIDER: S-EPMC3906312 | BioStudies | 2013-01-01

REPOSITORIES: biostudies

Similar Datasets

2016-01-01 | S-EPMC4738096 | BioStudies
2020-01-01 | S-EPMC7445348 | BioStudies
2013-01-01 | S-EPMC3957421 | BioStudies
1000-01-01 | S-EPMC4011919 | BioStudies
2019-01-01 | S-EPMC6702952 | BioStudies
1000-01-01 | S-EPMC5372081 | BioStudies
2017-01-01 | S-EPMC5514896 | BioStudies
1000-01-01 | S-EPMC4966511 | BioStudies
1000-01-01 | S-EPMC5048169 | BioStudies
2014-01-01 | S-EPMC3907754 | BioStudies